+ All Categories
Home > Documents > McIntyre_Enterocutaneous_fistula_2010.pdf

McIntyre_Enterocutaneous_fistula_2010.pdf

Date post: 04-Jun-2018
Category:
Upload: alexandra-yoelita
View: 217 times
Download: 0 times
Share this document with a friend

of 19

Transcript
  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    1/19

    Management of

    Enterocutaneous FistulaP. Bernard McIntyre, M.D.

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    2/19

    Enterocutaneous Fistula Mistakes

    Not operating early

    enough!

    Operating too

    early!

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    3/19

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    4/19

    Question 2 There is no need for anyone to wait

    greater than 12 weeks for attempt at repair

    of enterocutaneous fistula

    A. True

    B. False

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    5/19

    Question 3

    Direct suture repair of exposed fistulas is

    futileA. True

    B. False

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    6/19

    Etiology

    Malignancy

    Radiation Crohns Disease

    Post-operative ( 80% 90 % )

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    7/19

    Management

    Phase 1: Stabilization Phase 2: Anatomical definition

    Phase 3: Definitive operation

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    8/19

    Stabilization

    Fluid and electrolyte imbalances

    Measure fistula losses & electrolyte content if

    high output (>500 ml)

    Additional HCO replacement may be needed

    with duodenal or pancreatic fistulas

    H antagonist or PPI

    Octreotide may reduce fistula output & shortentime to closure. No evidence to support fistula

    closure. May affect immune function.

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    9/19

    Stabilization

    Sepsis control

    Broad spectrum antibiotics Percutaneous drainage

    Laparotomy if needed for source control

    Nutrition

    Enteral feeding, if feasible (100cm bowel distal orproximal to fistula)

    Parenteral feeding may be needed as supplement to

    enteral feeds

    No level 1 evidence to favor either route

    ? Fish oil and omega-3 fatty acids

    Skin care

    The stomal therapist is your friend!

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    10/19

    Enteroatmospheric Fistula

    incidence, > 50% mortality

    Largely preventable

    Avoid negative-pressure or gauze dressings

    directly on exposed bowel

    Early split-thickness or cadaver skin grafting

    to granulating surface

    Obliterative peritonitis precludes early repair

    (< 6 months)

    Effluent control difficult ( avoid tube drainage)

    Some success with local suturing and grafting

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    11/19

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    12/19

    VAC System

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    13/19

    Effluent Collecting System

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    14/19

    Anatomical definition

    Develop information to assess likelihood of

    spontaneous closure (15% - 71%))

    Stomach, lateral duodenum, lig. of Treitz,

    and distal ileum all unfavorable sites

    Fistulograms, contrast studies, CTs may

    all play a role in defining anatomy

    Wait for established tract (>10 days) for

    studies

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    15/19

    Anatomic Features Unfavourable

    for Spontaneous Closure

    Foreign body

    Radiation

    Inflammation / Infection

    Epithelialization of the tract

    Neoplasm Distal obstruction

    Short tract or > 1 cm enteral defect

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    16/19

    Definitive operation

    Timing is everything!

    Shake test Ureteral stenting if expecting dense adhesions

    Enter abdominal cavity in easiest area (upper

    midline)

    Lyse adhesions from stomach to colon

    Repair serosal tears and enterotomies as

    encountered

    Segmental bowel resection of fistula site

    Component separation or skin only closure

    acceptable . Plastics may need to help

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    17/19

    Extreme

    Great

    Moderate

    Minimal

    Time after Operation

    Severity of Adhesions

    0 7 14 21 28 42 56 84 6 months

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    18/19

    Definitive operation

    Timing is everything!

    Shake test Ureteral stenting if expecting dense adhesions

    Enter abdominal cavity in easiest area (upper

    midline) Lyse adhesions from stomach to colon

    Repair serosal tears and enterotomies as

    encountered

    Segmental bowel resection of fistula site

    Component separation or skin only closure

    acceptable . Plastics may need to help.

  • 8/13/2019 McIntyre_Enterocutaneous_fistula_2010.pdf

    19/19

    Conclusions

    ECF remains a difficult management

    problem, especially EAF

    The basis of management remains control

    of sepsis and fistula effluent with ongoing

    nutritional maintenance

    Early surgery should be limited to abscess

    drainage and proximal defunctioning

    stoma

    Definitive procedures for persistent ECF

    should take place several months later

    with resection of the fistulous segment


Recommended